These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 28880857)

  • 1. BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014.
    Kolor K; Chen Z; Grosse SD; Rodriguez JL; Green RF; Dotson WD; Bowen MS; Lynch JA; Khoury MJ
    MMWR Surveill Summ; 2017 Sep; 66(15):1-11. PubMed ID: 28880857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive Cancer Incidence, 2004-2013, and Deaths, 2006-2015, in Nonmetropolitan and Metropolitan Counties - United States.
    Henley SJ; Anderson RN; Thomas CC; Massetti GM; Peaker B; Richardson LC
    MMWR Surveill Summ; 2017 Jul; 66(14):1-13. PubMed ID: 28683054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie's New York Times editorial.
    Desai S; Jena AB
    BMJ; 2016 Dec; 355():i6357. PubMed ID: 27974323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receipt of Selected Preventive Health Services for Women and Men of Reproductive Age - United States, 2011-2013.
    Pazol K; Robbins CL; Black LI; Ahrens KA; Daniels K; Chandra A; Vahratian A; Gavin LE
    MMWR Surveill Summ; 2017 Oct; 66(20):1-31. PubMed ID: 29073129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
    Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
    JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas - United States.
    Mack KA; Jones CM; Ballesteros MF
    MMWR Surveill Summ; 2017 Oct; 66(19):1-12. PubMed ID: 29049278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentially Excess Deaths from the Five Leading Causes of Death in Metropolitan and Nonmetropolitan Counties - United States, 2010-2017.
    Garcia MC; Rossen LM; Bastian B; Faul M; Dowling NF; Thomas CC; Schieb L; Hong Y; Yoon PW; Iademarco MF
    MMWR Surveill Summ; 2019 Nov; 68(10):1-11. PubMed ID: 31697657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventable Premature Deaths from the Five Leading Causes of Death in Nonmetropolitan and Metropolitan Counties, United States, 2010-2022.
    García MC; Rossen LM; Matthews K; Guy G; Trivers KF; Thomas CC; Schieb L; Iademarco MF
    MMWR Surveill Summ; 2024 May; 73(2):1-11. PubMed ID: 38687830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
    JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
    Cragun D; Weidner A; Lewis C; Bonner D; Kim J; Vadaparampil ST; Pal T
    Cancer; 2017 Jul; 123(13):2497-2505. PubMed ID: 28182268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas-United States.
    Mack KA; Jones CM; Ballesteros MF
    Am J Transplant; 2017 Dec; 17(12):3241-3252. PubMed ID: 29145698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receipt of preventive counseling among reproductive-aged women in rural and urban communities.
    McCall-Hosenfeld JS; Weisman CS
    Rural Remote Health; 2011; 11(1):1617. PubMed ID: 21280972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
    Nelson HD; Pappas M; Zakher B; Mitchell JP; Okinaka-Hu L; Fu R
    Ann Intern Med; 2014 Feb; 160(4):255-66. PubMed ID: 24366442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leading Causes of Death in Nonmetropolitan and Metropolitan Areas- United States, 1999-2014.
    Moy E; Garcia MC; Bastian B; Rossen LM; Ingram DD; Faul M; Massetti GM; Thomas CC; Hong Y; Yoon PW; Iademarco MF
    MMWR Surveill Summ; 2017 Jan; 66(1):1-8. PubMed ID: 28081058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA testing in unaffected young women in the United States, 2006-2017.
    Guo F; Scholl M; Fuchs EL; Berenson AB; Kuo YF
    Cancer; 2020 Jan; 126(2):337-343. PubMed ID: 31568561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2014 Feb; 160(4):I-16. PubMed ID: 24366402
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.
    Nelson HD; Huffman LH; Fu R; Harris EL;
    Ann Intern Med; 2005 Sep; 143(5):362-79. PubMed ID: 16144895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in BRCA testing: when insurance coverage is not a barrier.
    Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
    Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.